Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia

PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
COVID-19Pneumonia
Interventions
DRUG

Standard of Care (SOC) + ANG-3777

Standard of Care (SOC) + ANG-3777

DRUG

Standard Of Care (SOC) + Placebo

Standard Of Care + Placebo

Trial Locations (10)

Unknown

Hospital Vera Cruz - NUPEC Nucleo de Pesquisa Clínica, Belo Horizonte

Santa Casa de Misericórdia de Porto Alegre, Porto Alegre

Pontifícia Universidade Catolica de Campinas, Campinas

UPCLIN - Faculdade de Medicina da UNESP Campus de Botucatu, Botucatu

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRP), Ribeirão Preto

Hospital Alemao Oswaldo Cruz, São Paulo

Hospital Heliópolis-SP, São Paulo

Hospital Vila Nova Star, São Paulo

Irmandade da Santa Casa de Misericórdia de São, São Paulo

Santa Casa de Misericordia de Sao Paulo, São Paulo

All Listed Sponsors
collaborator

CTI Clinical Trial and Consulting Services

OTHER

lead

Angion Biomedica Corp

INDUSTRY